Category: San Jose
user warning: Table './cburns2_drpl/accesslog' is marked as crashed and should be repaired
query: INSERT INTO accesslog (title, path, url, hostname, uid, sid, timer, timestamp) values('Juice Conference 2.0 – Announces Four Major Speakers', 'node/244', '', '38.107.179.234', 0, '8fe97a22ba3842e8c3d67eba43c5a2d2', 1248, 1329235804) in /home/cburns2/public_html/luminogenics/modules/statistics/statistics.module on line 64.
Firms Offer EBC Companies Access to Leading Design Software to Speed Time to Market for Clean Energy and Environmental Technologies
SAN JOSE and SAN RAFAEL, Calif., July 13, 2010 — Autodesk, Inc. (NASDAQ: ADSK) and the Environmental Business Cluster (EBC) have forged an industry partnership to offer benefits of the Autodesk Clean Tech Partner Program to the EBC community so companies can innovate and commercialize their ideas more quickly.
EBC is an award-winning clean tech incubator in Silicon Valley that provides commercialization support and facilities for emerging clean energy and environmental technology companies. The Autodesk Clean Tech Partner Program provides Digital Prototyping software to clean technology companies to enable them to digitally design, visualize and simulate the real-world performance of products before they are built. Creation of digital prototypes can serve as a catalyst to help participants secure financing and effectively market their ideas.
Now, more than ever, start-ups can use all the help they can get. The San Jose BioCenter will provide your biotech or cleantech company with support for fundraising, business development, legal, lab support, HR and payroll activities, as well as, provide you with access to our $15 million dollar state-of-the-art laboratory facilities and shared equipment.
“In just 5 years San Jose BioCenter companies have raised over $1 Billion in deals and financing.” -Melinda Richter, Executive Director, San Jose BioCenter
Our mission is to provide life science and cleantech companies with the infrastructure, resources, networks and expertise they need to develop and commercialize their technology. The San Jose BioCenter was awarded the National Business Incubator Association (NBIA) International Incubator of the year award for 2009 because of our exceptional resources, programs and client success rate. After 1.5 years at the San Jose BioCenter, Tacere Pharmaceuticals inked a $145m development deal with Pfizer for its preclinical hepatitis C drug:
Date: Thursday, October 22, 2009
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $100 to $225
Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the “Meet with...” Series, we provide emerging companies with greater access to partnering and/or financing opportunities. In this session, Senior Managers from Genentech, Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, each attendee will be granted a private meeting with Anna Williamson or Peter Condon, both Senior Manager of Business Development at Genentech, Inc.
Date: Friday, October 9, 2009
Time: 9:30-11:30AM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: from $0 to $40
Is your small business on the brink of taking its innovative cancer research to the next level but is in need of early-stage technology financing?
I recently talked with Melinda Richter, executive director of the San Jose BioCenter, and we spoke about bioincubation in California and what the BioCenter is doing to help young companies bring better therapies to market sooner.
I recently spoke with Aurelie Gaudin from the San Jose BioCenter, we talked briefly about the BioCenter's program of events to aid Residents and Affiliates in developing business strategies and gaining access to industry connections and contacts.
While many of the workshops and roundtables are specialized to the client's requirements, they are currently involved in a collaboration with BioCenter Premier Sponsor Orrick, Herrington & Sutcliffe LLP, where attendees may seek professional perspectives on relevant topics; and the "Meet with..." series where participants are able to meet with session speakers one on one.
An upcoming workshop at Orrick's facility in Menlo Park on September 10, has the topic of Patent Term Extensions and New Patent Office Rules; on September 22, Orrick will be hosting an industry panel discussion on the topic of Financial Darwinism: Which Companies are the Fittest.
The "Meet with..." sessions are exclusive events that must be registered for in advance. On September 24, at the BioCenter, attendees will meet with Licensing Directors from Merck and Co. Inc., the registration deadline for the event is today, September 4. Upcoming "Meet with..." events include meeting with Senior Managers from Genentech Inc., on October 22, and representatives from Nycomed in November, and Johnson & Johnson, Inc., in December.
The San Jose BioCenter is a non-profit business incubator in partnership with the City of San Jose, San Jose State University Research Foundation, and Prescience International. The San Jose BioCenter has won international acclaim and recognition for its incubation program.
The San Jose BioCenter has recently been awarded two prestigious, awards for incubation. The National Business Incubation Association's, Randall M. Whaley
Incubator of the Year Award, and the Dinah Adkins Incubator of the Year Award, in the category of Technology with a cash prize of $2,000. The BioCenter is located
in Edenvale Technology Park in San Jose, California. The 40,000 square foot BioCenter provides business and facility services to solvent, compelling, technology companies with identifiable IP assets in the fields of the life sciences, nanotech or cleantech. The BioCenter is a partnership between the City of San Jose, San Jose State University Research Foundation and Prescience International. Since the BioCenter's inception in 2004, incubated companies have raised $800 million in capital and injected more than 600 high technology jobs into the local economy.
